From Dollars to Debate: Why Clinical Trials are at a Crossroad

At the risk of a grievous understatement, 2025 has brought significant shifts in US federal funding priorities Clinical research, long dependent on support from the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and CMS, is feeling the ripple effects. It’s still early but we are already observing that budget reallocation impacts […]